BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19657144)

  • 1. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton.
    Almeida M; Ambrogini E; Han L; Manolagas SC; Jilka RL
    J Biol Chem; 2009 Oct; 284(40):27438-48. PubMed ID: 19657144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.
    Jilka RL; Almeida M; Ambrogini E; Han L; Roberson PK; Weinstein RS; Manolagas SC
    Aging Cell; 2010 Oct; 9(5):851-67. PubMed ID: 20698835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.
    Liu Y; Almeida M; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E762-73. PubMed ID: 26956187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription.
    Almeida M; Han L; Martin-Millan M; O'Brien CA; Manolagas SC
    J Biol Chem; 2007 Sep; 282(37):27298-27305. PubMed ID: 17623658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
    Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
    J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma.
    Kang S; Bennett CN; Gerin I; Rapp LA; Hankenson KD; Macdougald OA
    J Biol Chem; 2007 May; 282(19):14515-24. PubMed ID: 17351296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.
    Ali AA; Weinstein RS; Stewart SA; Parfitt AM; Manolagas SC; Jilka RL
    Endocrinology; 2005 Mar; 146(3):1226-35. PubMed ID: 15591153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass.
    Kolli V; Stechschulte LA; Dowling AR; Rahman S; Czernik PJ; Lecka-Czernik B
    PLoS One; 2014; 9(5):e96323. PubMed ID: 24810249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.
    Manolagas SC; Almeida M
    Mol Endocrinol; 2007 Nov; 21(11):2605-14. PubMed ID: 17622581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells.
    Yuan Z; Li Q; Luo S; Liu Z; Luo D; Zhang B; Zhang D; Rao P; Xiao J
    Curr Stem Cell Res Ther; 2016; 11(3):216-25. PubMed ID: 25986621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats.
    Lin TH; Yang RS; Tang CH; Lin CP; Fu WM
    Bone; 2007 Oct; 41(4):562-74. PubMed ID: 17669705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
    Vallée A; Lecarpentier Y
    Front Immunol; 2018; 9():745. PubMed ID: 29706964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts.
    Almeida M; Han L; Ambrogini E; Weinstein RS; Manolagas SC
    J Biol Chem; 2011 Dec; 286(52):44326-35. PubMed ID: 22030390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling.
    Yan J; Li B; Chen JW; Jiang SD; Jiang LS
    J Cell Mol Med; 2012 Dec; 16(12):2968-77. PubMed ID: 22947224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
    Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
    EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease?
    Kirton JP; Crofts NJ; George SJ; Brennan K; Canfield AE
    Circ Res; 2007 Sep; 101(6):581-9. PubMed ID: 17673669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
    Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
    Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones Inhibit Mouse Osteoblastic MC3T3-E1 Cell Proliferation in Part Through the Wnt Signaling Pathway.
    Duan M; Zhou B; Zhou X; Yuan G
    J Investig Med; 2015 Jun; 63(5):758-64. PubMed ID: 25756249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.